1.64
price down icon0.61%   -0.01
after-market Handel nachbörslich: 1.64
loading

Finanzdaten der Alzamend Neuro Inc-Aktie (ALZN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
8.33%
2.6599
2.9017 3.5259 - -
Interest Income/Expense
42.29%
0.00249
0.00431 0.00184 0.000519 0.00206
Operating Income/Loss
8.33%
-2.6599
-2.9017 -3.5259 -3.305 -5.4235
Nonoperating Income/Loss
42.29%
-0.00249
-0.00431 -0.00184 -0.000519 -0.00206
Income/Loss From Continuing Operations Before Tax
192.91%
2.70
-2.906 3.50 -26.48 5.40
Income/Loss From Continuing Operations After Tax
192.91%
2.70
-2.906 3.50 -26.48 5.40
Net Income/Loss
192.91%
2.70
-2.906 3.50 3.30 5.40
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
5.3624
- 7.0278 6.6055 10.83
Basic Average Shares
7.47%
7.0543
6.5638 98.44 - -
Diluted Average Shares
7.47%
7.0543
6.5638 98.44 -0.2465 98.33
Basic Earnings Per Share
13.64%
-0.38
-0.44 -0.04 -0.03 -0.06
Diluted Earnings Per Share
13.64%
-0.38
-0.44 -0.04 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):